TILT BIOTHERAPEUTICS OY
Y-tunnus 2544020-5 · 5 myöntöä EU FTS -lähteistä
Yrityksen profiili yritysvahdissa →
Yhteensä4 689 223 €
EU FTS4 689 223 €
Rahoitus vuosittain
| Vuosi | Summa |
|---|---|
| 2022 | 2 100 000 € |
| 2018 | 2 050 932 € |
| 2015 | 538 291 € |
Myönnöt
- 190121193 - I-CREATE - FIGHTING CANCER WITH NEXT GENERATION ONCOLYTIC IMMUNOTHERAPY IN OVARIAN, HEAD & NECK, AND LUNG CANCERS (IMMUNE CHECKPOINT RESPONSE ENABLING ADENOVIRUS TECHNOLOGY )Euroopan komissio · Horizon Europe (X)
- 190121193 - I-CREATE - FIGHTING CANCER WITH NEXT GENERATION ONCOLYTIC IMMUNOTHERAPY IN OVARIAN, HEAD & NECK, AND LUNG CANCERS (IMMUNE CHECKPOINT RESPONSE ENABLING ADENOVIRUS TECHNOLOGY )Euroopan komissio · Horizon Europe (X)
- 811693 - UNLEASHAD - UNLEASHING THE CURATIVE POTENTIAL OF CANCER IMMUNOTHERAPYEuroopan komissio · Horizon 2020 (X)
- 813453 - STACCATO - EUROPEAN INDUSTRIAL DOCTORATE FOR ENHANCING UPSTREAM BIOPHARMACEUTICAL MANUFACTURING PROCESS DEVELOPMENT THROUGH SINGLE CELL ANALYSISEuroopan komissio · Horizon 2020 (REA)
- 643130 - VIRION - VIRUSES, IMMUNE STIMULATION AND RNA INTERFERENCE IN ONCOLOGY NETWORKEuroopan komissio · Horizon 2020 (REA)
Lähde: Euroopan komissio / Financial Transparency System